CLOs on the Move

EUSA Pharma

www.eusapharma.com

 
EUSA Pharma is a specialty pharma company with a strong and growing portfolio of specialty hospital medicines. It has been built through the acquisition of Talisker Pharmaceuticals in July 2006 and OPi in March 2007. Our primary marketed products are
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million
  • www.eusapharma.com
  • 1717 Langhorne Newtown Rd Ste 201
    Langhorne, PA USA 19047
  • Phone: 215.867.4900

Executives

Name Title Contact Details

Similar Companies

Denton County MHMR Center

Denton County MHMR Center mission is to enhance the quality of life of the individuals served and their family members. Crisis Line 24/7: 1-800-762-0157

Teva Canada Innovations.

Teva Canada Innovations. is a MontríŠal, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Reata Pharmaceuticals

Reata Pharmaceuticals is the leader in discovering and developing novel, oral anti-inflammatory drugs that activate Nrf2, the primary regulator of cellular antioxidant and detoxification enzymes.

Allstar Genetics

Allstar Genetics is a Celina, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ancillare

Ancillary Supply Chain, Simplified Ancillare is the leader in end-to-end global clinical trial ancillary supply chain management needs of large- and middle-market pharmaceutical, biotechnology, and medical device companies, as well as contract and medical research organizations. Ancillare is the first organization of its kind with an exclusive focus on the global clinical trial ancillary supply chain. Ancillare arms sponsors of global clinical trials with a customized, end-to-end Ancillare Supply Plan, enabling developers of new therapies to optimize their clinical study supply chains using streamlined processes, extensive global buying power, a vast depot network and proven teams of clinical, procurement, operations, logistics, and regulatory experts. Ancillare`s Turn-Key Operations (A-TKO™) model embraces the complexities and globalization of the clinical and ancillary supply chain by reducing both the overall cost and cycle time of clinical trials, and greatly improving operational efficiency across all levels of the value chain. Ancillare has supported more than 1,500 clinical trials across 80,000 clinical sites over 100 countries with master depots in United States, United Kingdom, and Singapore, and strategic depots in Argentina, Australia, Brazil, Canada, Chile, China, Colombia, India, Israel, Japan, Korea, Mexico, Panama, Peru, Philippines, Russia, South Africa, Taiwan, and Ukraine.